BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 55372)

  • 1. Hepatitis BS antigen, malaria titers, and primary liver cancer in South Vietnam.
    Welsh JD; Brown JD; Arnold K; Mathews HM; Prince AM
    Gastroenterology; 1976 Mar; 70(3):392-6. PubMed ID: 55372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Primary liver cancer and hepatitis B infection in Senegal. Comparison of cancer patients with 2 control groups].
    Michon J; Prince AM; Szmuness W; Demaille J; Diebolt G; Linhard J; Quenum C; Sankale M
    Biomedicine; 1975 Sep; 23(7):263-266. PubMed ID: 60144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hepatitis B and primary cancer of the liver in intertropical Africa].
    Coursaget P; Yvonnet B; Barres JL; Perrin J; Tortey E; Diop B; Kocheleff P; Duflo B; M'Boup S; Diop-Mar I
    Rev Epidemiol Sante Publique; 1985; 33(4-5):267-75. PubMed ID: 2419946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B virus and primary liver carcinoma: evidences for a filiation hepatitis B, cirrhosis and primary liver cancer.
    Maupas P; Coursaget P; Goudeau A; Drucker J; Sankale M; Linhard J; Diebolt G
    Ann Microbiol (Paris); 1977; 128(2):245-53. PubMed ID: 71006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistence of circulating complexes between HBsAg and immunoglobulin M in sera of hepatitis B surface antigen positive patients suffering from liver cirrhosis or primary liver cancer.
    Coursaget P; Barres JL; Tortey E; Cotty P; Diop T; Yvonnet B; Sow MT; Mboup S; Diop B; Bocande JE
    Cancer Res; 1986 Mar; 46(3):1492-4. PubMed ID: 3943106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological features of hepatocellular carcinoma--comparison of hepatitis B seropositive and seronegative patients.
    Okuda H; Obata H; Motoike Y; Hisamitsu T
    Hepatogastroenterology; 1984 Apr; 31(2):64-8. PubMed ID: 6202615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B viral markers in patients with primary hepatocellular carcinoma in Taiwan.
    Chien MC; Tong MJ; Lo KJ; Lee JK; Milich DR; Vyas GN; Murphy BL
    J Natl Cancer Inst; 1981 Mar; 66(3):475-9. PubMed ID: 6162990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-fetoprotein and hepatitis B antigen in acute hepatitis and primary cancer of the liver.
    Ruoslahti E; Seppälä M; Räsänen JA; Vuopio P; Helske T
    Scand J Gastroenterol; 1973; 8(3):197-202. PubMed ID: 4125123
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatitis B viral markers in Nigerian patients with primary liver carcinoma.
    Gashau W; Mohammed I
    Trop Geogr Med; 1991; 43(1-2):64-7. PubMed ID: 1721465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B x antigen in hepatitis B virus carrier patients with liver cancer.
    Wang WL; London WT; Feitelson MA
    Cancer Res; 1991 Sep; 51(18):4971-7. PubMed ID: 1654208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B virus serological markers in Africans with liver cirrhosis and hepatocellular carcinoma.
    Coursaget P; Chiron JP; Barres JL; Barin F; Cottey P; Tortey E; Yvonnet B; Diop B; MBoup S; Diop-Mar I
    IARC Sci Publ; 1984; (63):181-98. PubMed ID: 6085625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Early diagnosis of alpha fetoprotein nonproducing primary liver cancer].
    Ma ZC
    Zhonghua Zhong Liu Za Zhi; 1990 Mar; 12(2):111-3. PubMed ID: 1698135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of alpha-fetoprotein in primary liver cancer in Tanzania.
    Spencer SS; Lindqvist KJ; Nantulya VM
    East Afr Med J; 1991 Aug; 68(8):595-600. PubMed ID: 1722452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-mediated immune reactivity to hepatitis B surface antigen in liver diseases.
    de Moura MC; Vernace SJ; Paronetto F
    Gastroenterology; 1975 Aug; 69(2):310-17. PubMed ID: 1080122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serological differential diagnosis of viral hepatitis in adults.
    Hollós I; László B; Pálfi A; Szécsey G; Novák E
    Acta Microbiol Acad Sci Hung; 1976; 23(1):29-40. PubMed ID: 180757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune response in fulminant viral hepatitis, type B.
    Tabor E; Gerety RJ; Hoofnagle JH; Barker LF
    Gastroenterology; 1976 Oct; 71(4):635-40. PubMed ID: 60267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis markers in Malaysians with hepatocellular carcinoma.
    Lopez JB; Thambyrajah V; Balasegaram M; Satgunasingam N
    Br J Biomed Sci; 1994 Jun; 51(2):177-80. PubMed ID: 7519505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis Be antigen and antibody in chronic liver diseases and hepatocellular carcinoma.
    Chen DS; Sung JL; Lai MY
    Hepatogastroenterology; 1981 Dec; 28(6):288-91. PubMed ID: 6284625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.
    Murugavel KG; Mathews S; Jayanthi V; Shankar EM; Hari R; Surendran R; Vengatesan A; Raghuram K; Rajasambandam P; Murali A; Srinivas U; Palaniswamy KR; Pugazhendhi T; Thyagarajan SP
    Int J Infect Dis; 2008 Nov; 12(6):e71-6. PubMed ID: 18658001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical significance of HBeAg and anti-HBe in HBsAg positive liver diseases].
    Takahashi A; Sekiya C; Yazaki Y; Tominaga Y; Oohara K; Ono M; Sato H; Hasebe C; Namiki M
    Hokkaido Igaku Zasshi; 1983 Jan; 58(1):30-42. PubMed ID: 6840666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.